Recent advances in patient selection and devices for transcatheter edge-to-edge mitral valve repair in heart failure

References

• Goel SS, Bajaj N, Aggarwal B, et al. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need. J Am Coll Cardiol. 2014;63:185–186.
   PubMed Web of Science ®Google Scholar
• Goliasch G, Bartko PE, Pavo N, et al. Refining the prognostic impact of functional mitral regurgitation in chronic heart failure. Eur Heart J. 2018;39(1):39–46.
   PubMed Web of Science ®Google Scholar
• Lancellotti P, Moura L, Pierard LA, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr. 2010;11:307–332.
   PubMed Web of Science ®Google Scholar
• Maisano F, Torracca L, Oppizzi M, et al. The edge-to-edge technique: a simplified method to correct mitral insufficiency. Eur J Cardiothorac Surg. 1998;13:240–245. discussion 245-246
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016Jul 14;37(27):2129–2200.
   Web of Science ®Google Scholar
• Orban M, Braun D, Orban M, et al. Established interventions for mitral valve regurgitation: current evidence. Herz. 2016;41:19–25.
   PubMed Web of Science ®Google Scholar
• Bursi F, Barbieri A, Grigioni F, et al. Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long-term outcome study. Eur J Heart Fail. 2010;12:382–388.
   PubMed Web of Science ®Google Scholar
• Patel JB, Borgeson DD, Barnes ME, et al. Mitral regurgitation in patients with advanced systolic heart failure. J Card Fail. 2004;10:285–291.
   PubMed Web of Science ®Google Scholar
• Bandera F, Generati G, Pellegrino M, et al. Mitral regurgitation in heart failure: insights from CPET combined with exercise echocardiography. Eur Heart J Cardiovasc Imaging. 2017Mar 1;18(3):296–303.
   Web of Science ®Google Scholar
• Cioffi G, Tarantini L, De Feo S, et al. Functional mitral regurgitation predicts 1-year mortality in elderly patients with systolic chronic heart failure. Eur J Heart Fail. 2005;7:1112–1117.
   PubMed Web of Science ®Google Scholar
• Grigioni F, Enriquez-Sarano M, Zehr KJ, et al. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103:1759–1764.
   PubMed Web of Science ®Google Scholar
• Kriechbaum SD, Boeder NF, Gaede L, et al. Mitral valve leaflet repair with the new PASCAL system: early real-world data from a German multicentre experience. Clin Res Cardiol. 2019 Aug 26. doi: 10.1007/s00392-019-01538-3.  Epub ahead of print.
   PubMedGoogle Scholar
• Rossi A, Dini FL, Faggiano P, et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart. 2011;97:1675–1680.
   PubMed Web of Science ®Google Scholar
• Trichon BH, Felker GM, Shaw LK, et al. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol. 2003;91:538–543.
   PubMed Web of Science ®Google Scholar
• Wallenborn J, Stork S, Herrmann S, et al. Prevalence of severe mitral regurgitation eligible for edge-to-edge mitral valve repair (MitraClip). Clin Res Cardiol. 2016;105:699–709.
   PubMed Web of Science ®Google Scholar
• Baumgartner H, Falk V, Bax JJ, et al.; for the ESC Scientific Document Group. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:1791–2739.
   Web of Science ®Google Scholar
• Braun D, Rommel KP, Orban M, et al. Acute and short-term results of transcatheter edge-to-edge repair for severe tricuspid regurgitation using the MitraClip XTR system. JACC Cardiovasc Interv. 2019;12:604–605.
   PubMed Web of Science ®Google Scholar
• Grayburn PA, Sannino A, Packer M. Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT trials. JACC Cardiovasc Imaging. 2019;12:353–362.
   PubMed Web of Science ®Google Scholar
• Jorbenadze R, Schreieck J, Barthel C, et al. Percutaneous edge-to-edge mitral valve repair using the new MitraClip XTR system. JACC Cardiovasc Interv. 2018;11:e93–e95.
   PubMed Web of Science ®Google Scholar
• Koelling TM, Aaronson KD, Cody RJ, et al. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J. 2002;144:524–529.
   PubMed Web of Science ®Google Scholar
• Kreusser MM, Geis NA, Berlin N, et al. Invasive hemodynamics and cardiac biomarkers to predict outcomes after percutaneous edge-to-edge mitral valve repair in patients with severe heart failure. Clin Res Cardiol. 2019;108:375–387.
   PubMed Web of Science ®Google Scholar
• Praz F, Braun D, Unterhuber M, et al. Edge-to-edge mitral valve repair with extended clip arms early. Experience from a multicenter observational study. JACC Cardiovasc Interv. 2019 Jul 22;12(14):1356–1365.
   Web of Science ®Google Scholar
• Stone G COAPT: A randomized trial of transcatheter mitral valve leaflet approximation in patients with heart failure and secondary mitral regurgitation. Congress Presentation TCT; 2018.
   Google Scholar
• Swaans MJ, Bakker AL, Alipour A, et al. Survival of transcatheter mitral valve repair compared with surgical and conservative treatment in high-surgical-risk patients. JACC Cardiovasc Interv. 2014;7:875–881.
   PubMed Web of Science ®Google Scholar
• Velazquez EJ, Samad Z, Al-Khalidi HR, et al. The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: A propensity-matched comparison. Am Heart J. 2015;170:1050–1059.
   PubMed Web of Science ®Google Scholar
• Vahanian A, Vahanian A, Alfieri O, et al. Guidelines on the management of valvular heart disease (version 2012) joint task force on the management of valvular heart disease of the European Society of C, European Association for cardio-thoracic S. Eur Heart J. 2012;33:2451–2496.
   PubMed Web of Science ®Google Scholar
• Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC Focused Update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2017;135:e1159–e1195.
   PubMed Web of Science ®Google Scholar
• Mihaljevic T, Lam BK, Rajeswaran J, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol. 2007;49:2191–2201.
   PubMed Web of Science ®Google Scholar
• Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374:344–353.
   PubMed Web of Science ®Google Scholar
• Michler RE, Smith PK, Parides MK, et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2016;374:1932–1941.
   PubMed Web of Science ®Google Scholar
• Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28:1358–1365.
   PubMed Web of Science ®Google Scholar
• Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395–1406.
   PubMed Web of Science ®Google Scholar
• Franzen O, van der Heyden J, Baldus S, et al. MitraClip(R) therapy in patients with end-stage systolic heart failure. Eur J Heart Fail. 2011;13:569–576.
   PubMed Web of Science ®Google Scholar
• Geis NA, Puls M, Lubos E, et al. Safety and efficacy of MitraClip therapy in patients with severely impaired left ventricular ejection fraction: results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail. 2018;20:598–608.
   PubMed Web of Science ®Google Scholar
• Chiarito M, Pagnesi M, Martino E, et al. Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis. Heart. 2018;104:306–312.
   PubMed Web of Science ®Google Scholar
• Obadia JF, Messika-Zeitoun D, Leurent G, et al.; for the MITRA-FR Investigators. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018;379:2297–2306.
   PubMed Web of Science ®Google Scholar
• Buzzatti N, Maisano F, Latib A, et al. Comparison of outcomes of percutaneous MitraClip versus surgical repair or replacement for degenerative mitral regurgitation in octogenarians. Am J Cardiol. 2015;115:487–492.
   PubMed Web of Science ®Google Scholar
• Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I clinical trial. J Am Coll Cardiol. 2005;46:2134–2140.
   PubMed Web of Science ®Google Scholar
• Auricchio A, Schillinger W, Meyer S, et al. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol. 2011;58:2183–2189.
   PubMed Web of Science ®Google Scholar
• Glower DD, Kar S, Trento A, et al. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. J Am Coll Cardiol. 2014;64:172–181.
   PubMed Web of Science ®Google Scholar
• Orban M, Braun D, Orban M, et al. Long-term outcome of patients with severe biventricular heart failure and severe mitral regurgitation after percutaneous edge-to-edge mitral valve repair. J Interv Cardiol. 2015;28:164–171.
   PubMed Web of Science ®Google Scholar
• Puls M, Lubos E, Boekstegers P, et al. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur Heart J. 2016;37:703–712.
   PubMed Web of Science ®Google Scholar
• Rudolph V, Huntgeburth M, von Bardeleben RS, et al. Clinical outcome of critically ill, not fully recompensated, patients undergoing MitraClip therapy. Eur J Heart Fail. 2014;16:1223–1229.
   PubMed Web of Science ®Google Scholar
• SchuelerR, Nickenig G, May AE, et al. Predictors for short-term outcomes of patients undergoing transcatheter mitral valve interventions: analysis of 778 prospective patients from the German TRAMI registry focusing on baseline renal function. EuroIntervention. 2016 Jul 20;12(4) :508–514.
   Web of Science ®Google Scholar
• Giannini C, Petronio AS, De Carlo M, et al. Integrated reverse left and right ventricular remodelling after MitraClip implantation in functional mitral regurgitation: an echocardiographic study. Eur Heart J Cardiovasc Imaging. 2014;15:95–103.
   PubMed Web of Science ®Google Scholar
• Frangieh AH, Gruner C, Mikulicic F, et al. Impact of percutaneous mitral valve repair using the MitraClip system on tricuspid regurgitation. EuroIntervention. 2016;11:e1680–1686.
   PubMed Web of Science ®Google Scholar
• Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43:405–409.
   PubMed Web of Science ®Google Scholar
• Neuhold S, Huelsmann M, Pernicka E, et al. Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a long-term observational study. Eur Heart J. 2013;34:844–852.
   PubMed Web of Science ®Google Scholar
• Ohno Y, Attizzani GF, Capodanno D, et al. Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry. Eur Heart J Cardiovasc Imaging. 2014;15:1246–1255.
   PubMed Web of Science ®Google Scholar
• van Riel AC, Boerlage-van Dijk K, de Bruin-bon RH, et al. Percutaneous mitral valve repair preserves right ventricular function. J Am Soc Echocardiogr. 2014;27:1098–1106.
   PubMed Web of Science ®Google Scholar
• Vitarelli A, Mangieri E, Capotosto L, et al. Assessment of biventricular function by three-dimensional speckle-tracking echocardiography in secondary mitral regurgitation after repair with the mitraclip system. J Am Soc Echocardiogr. 2015;28:1070–1082.
   PubMed Web of Science ®Google Scholar
• Orban M, Orban M, Lesevic H, et al. Predictors for long-term survival after transcatheter edge-to-edge mitral valve repair. J Interv Cardiol. 2017;30:226–233.
   PubMed Web of Science ®Google Scholar
• Kalbacher D, Schäfer U, Bardeleben RSV, et al. Long-term outcome, survival and predictors of mortality after MitraClip therapy: results from the German Transcatheter mitral valve interventions (TRAMI) registry. Int J Cardiol. 2019;277:35–41.
   PubMed Web of Science ®Google Scholar
• Tigges E, Blankenberg S, von Bardeleben RS, et al. Implication of pulmonary hypertension in patients undergoing MitraClip therapy: results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail. 2018;20:585–594.
   PubMed Web of Science ®Google Scholar
• Kalbacher D, Schäfer U, von Bardeleben RS, et al. Impact of tricuspid valve regurgitation in surgical high-risk patients undergoing MitraClip implantation: results from the TRAMI registry. EuroIntervention. 2017;12:e1809–e1816.
   PubMed Web of Science ®Google Scholar
• Armeni P, Boscolo PR, Tarricone R, et al. Real-world cost effectiveness of MitraClip combined with medical therapy versus medical therapy alone in patients with moderate or severe mitral regurgitation. Int J Cardiol. 2016;209:153–160.
   PubMed Web of Science ®Google Scholar
• Schafer U, Maisano F, Butter C, et al. Impact of preprocedural left ventricular ejection fraction on 1-year outcomes after MitraClip Implantation (from the ACCESS-EU Phase I, a prospective, multicenter, nonrandomized postapproval study of the mitraclip therapy in Europe). Am J Cardiol. 2016;118:873–880.
   PubMed Web of Science ®Google Scholar
• Giannini C, Fiorelli F, De Carlo M, et al. Comparison of percutaneous mitral valve repair versus conservative treatment in severe functional mitral regurgitation. Am J Cardiol. 2016;117:271–277.
   PubMed Web of Science ®Google Scholar
• Stone GW, Lindenfeld J, Abraham WT, et al.; for the COAPT Investigators. Transcatheter mitralvalve repair in patients with heart failure. N Engl J Med. 2018;379:2307–2318.
   PubMed Web of Science ®Google Scholar
• Orban M, Hausleiter J. Percutaneous treatment of functional mitral regurgitation - Awaiting results of COAPT and MITRA-FR. Int J Cardiol. 2018;269:89–90.
   PubMed Web of Science ®Google Scholar
• Packer M. When cardiovascular trials collide. Eur Heart J. 2019;40:501–504.
   PubMed Web of Science ®Google Scholar
• Committees, McMurray JJ, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993–1004.
   PubMed Web of Science ®Google Scholar
• Iung B, Armoiry X, Vahanian A, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years. Eur J Heart Fail. 2019 Dec;21(12):1619–1627.
   Web of Science ®Google Scholar
• Abdelrahman N, Chowdhury MA, Al Nooryani A, et al. A case of dilated cardiomyopathy and severe mitral regurgitation treated using a combined percutaneous approach of MitraClip followed by CARILLON(R) mitral contour system. Cardiovasc Revasc Med. 2016 Dec;17(8):578–581.
   Google Scholar
• Grasso C, Attizzani GF, Ohno Y, et al. Catheter-based edge-to-edge mitral valve repair after percutaneous mitral valve annuloplasty failure. JACC Cardiovasc Interv. 2014;7:e85–86.
   PubMed Web of Science ®Google Scholar
• Siminiak T, Wu JC, Haude M, et al. Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail. 2012;14:931–938.
   PubMed Web of Science ®Google Scholar
• Maisano F, Taramasso M, Nickenig G, et al. Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. Eur Heart J. 2016;37:817–825.
   PubMed Web of Science ®Google Scholar
• Praz F, Spargias K, Chrissoheris M, et al. Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study. Lancet. 2017;390:773–780.
   PubMed Web of Science ®Google Scholar
• Grasso C, Popolo Rubbio A. The PASCAL transcatheter mitral valve repair system for the treatment of mitral regurgitation: another piece to the puzzle of edge-to-edge technique. J Thorac Dis. 2017;9:4856–4859.
   PubMed Web of Science ®Google Scholar
• Eggebrecht H, Schelle S, Puls M, et al. Risk and outcomes of complications during and after MitraClip implantation: experience in 828 patients from the German TRAnscatheter mitral valve interventions (TRAMI) registry. Catheter Cardiovasc Interv. 2015;86:728–735.
   PubMed Web of Science ®Google Scholar
• Grasso C, Capodanno D, Scandura S, et al. One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry). Am J Cardiol. 2013;111:1482–1487.
   PubMed Web of Science ®Google Scholar
• Maisano F, Franzen O, Baldus S, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol. 2013;62:1052–1061.
   PubMed Web of Science ®Google Scholar